Microbiology JC089: Defence Against Microbes Flashcards
Immune system
Double-edged sword
- Defence against microbes, Defence against cancers
- Allergic reaction, Autoimmune disease, Malignancy, Aberrant responses to infections
Innate immunity - Immediate (in place even before infection) - Non-specific - Limited diversity - No memory - ***Stimulate adaptive immune response - Consist of —> Physical + Chemical barriers —> ***Phagocytic cells (neutrophils, macrophages) —> ***NK cells —> Blood proteins e.g. ***complements —> Cytokines —> Platelet
Adaptive immunity - Needs time —> Stimulated by exposure to antigens —> ***Activation of lymphocytes —> Elimination of antigens - Specific - Very diverse - Memory - Consists of —> ***B + T Lymphocytes —> ***Antibodies
***Innate immune system
- Epithelial barrier
- skin, GI, genitourinary, respiratory tract - ***Antimicrobial peptides
- cathelicidins, defensins - Recognition of microbes
- **Pathogen-associated molecular patterns (PAMPs) (e.g. lipopolysaccharide, nucleic acid) of the microbes recognised by **Pattern recognition receptors (PRR) on host cell surface
—> **Toll-like receptor (TLR), **Nod-like receptor (NLR), ***RIG-1 like receptor (RLR)
—> Direct activation of Innate host-defence module by PRR
—> positive feedback to amplify immune response
—> eventually trigger adaptive immune response
—> specific clearance of pathogens + establish long term immunological memory against pathogen - Cells involved
- Neutrophils
- Macrophages
- NK cells - Complement system
- Communication
- by Cytokines
Complement system
- Plasma proteins that are activated by microbe
- Promotes destruction + inflammation
- Classical pathway (Ag-Ab complex bound by C1)
- Alternative pathway (Ag bound by C3b)
- Lectin pathway (Mannose bound by MBL)
—> Activation of C3
—> C3a (Inflammation), C3b (Opsonisation)
—> C5a (Inflammation)
—> C5b-C9 (MAC)
Adaptive immune response
Humoral:
- B cell —> Plasma cell —> Ab
Cellular:
- T cell
—> T helper cell (CD4+) —> Th1 (Cell-mediated immunity), Th2 (Humoral immunity), Th17
—> T cytotoxic cell (CD8+)
Antibody
- 2 Heavy chains
- 2 Light chains
- Fc fragment: Low portion, only heavy chains —> bind to Fc receptor
- Fab fragment: Upper portion, heavy + light chains —> bind to Ag
Functions
- Ab bind to pathogen / toxin
- **Neutralisation of toxin / viruses
- **Direct antimicrobial activity
- **Complement activation
- **Opsonisation (Ab-bound pathogen phagocytosed by neutrophils / macrophages)
- ***ADCC (trigger effector cells to kill targets via cell-mediated immunity e.g. Cytotoxic T cell response: CTL kill virus-infected cells / tumour cells) - Ab bind to host cells / tissues
- Immunomodulation
Types of Ab:
- IgM
- early phase of infection, appear before IgG - IgG
- appear later
- large amount in serum
- ***remain positive for long period of time - IgE
- bound to mast cell —> Type 1 hypersensitivity reaction - IgA
- secreted
- mucosal surfaces - IgD
- cell bound on B cell —> cell signaling
T cells
- Cytotoxic T cells (CD8+)
- eliminate intracellular microbes by killing infected cells - Helper T cells (CD4+) (Master regulator)
- Th1:
—> Phagocyte-mediated
—> **Intracellular microbes (bacteria / protozoa)
—> produce **IFNγ (e.g. in MTB)
- Th2:
—> Promote **IgE and Eosinophil / Basophil / Mast cell-mediated immune reactions
—> produce **IL-4 (e.g. Helminth infection)
—> also cause ***Atopy (e.g. Asthma) - Th17: Protect against **Extracellular bacterial + **Fungal infections
- Th1, 2, 17: Promote production of Ab from B cells
3. Regulatory T cells
Important clinical syndromes associated with immune defects: Impaired ***innate immunity
- Complement defects
- Neutrophils defects
- **Chronic granulomatous disease (CGD)
- **Leukocyte adhesion deficiency syndromes (LAD) - AutoAb against IFNγ
- Complement defects
Defects in:
- Classical pathway
- Encapsulated bacteria (e.g. S. pneumoniae, Hib, ***N. meningitidis) - Mannose binding lectin pathway
- Sinopulmonary infection
- ***N. meningitidis - Alternative pathway
- Less common
- ***N. meningitidis - Terminal components (C5-9)
- ***N. meningitidis
Implications: Must consider **meningococcal vaccination in treatment of **SLE which wipes out complement system
- Neutrophils defect
- Quantitative defect: **Neutropenia
- **Chemotherapy, Antibiotics
- ***Haematological malignancy - Qualitative defect: ***Chronic granulomatous disease
Problems:
1. Bacterial infection
- Gram +ve: Staphylococcus, Streptococcus, Enterococcus
- Gram -ve: E. coli, PA (>50% mortality)
—> Sepsis
- ***Neutropenic fever / Neutropenic sepsis: Medical emergency, life-threatening
- Fungus
- Candida
- Aspergillus, Fusarium, Zygomycetes
Chronic granulomatous disease (CGD)
- Usually X-linked (some autosomal recessive form p47)
- ***Abnormal respiratory burst oxidase activity —> Phagolysosome lacks superoxides / H2O2 to kill bacteria —> Defects in intracellular killing
- Susceptible to organisms that have ***strong catalase reactions: —> ***S. aureus —> Serratia marcescens —> Burkholderia cepacia —> Chromobacterium violaceum —> Nocardia —> Aspergillus —> Clinical presentation: Lymphadenitis
Leukocyte adhesion deficiency syndromes (LAD)
- Neutrophils functionally normal
- But **impaired adhesion of affected inflammatory cells within the vasculature, **inability to migrate into tissues
- Recurrent infections
—> Staphylococcus
—> Pseudomonas aeruginosa (disease: Ecthyma gangrenosum)
- AutoAb against IFNγ
- Adult onset
- ***Acquired condition
- Asian
IFNγ:
- involved in Innate + Adaptive immunity
- Type 2 IFN
- produced by NK cells, Th1, CTL
- part of IL12-IFNγ loop —> activate macrophage —> important to kill ***intracellular microbes
Microbes (***Intracellular): - NTM - Non-typhoidal salmonella - Burkholderia pseudomallei - Penicillium marneffei - VZV (- Cryptococcosis, Histoplasmosis)
Type 1 IFN
- Important for ***viral infections
- 10% COVID-19 patients with severe / life-threatening symptoms have AutoAb against Type 1 IFN
Important clinical syndromes associated with immune defects: Impaired ***adaptive immunity
- Impaired humoral immunity (lack Ab for opsonisation, complement activation)
- ***Encapsulated bacteria
—> S. pneumoniae
—> H. influenzae
- Diseases associated with Ab deficiencies / defects: Agammaglobulinaemia, IgA deficiency, Nephrotic syndrome
- Common variable immunodeficiency (CVID) - Impaired cell-mediated immunity
- ***Intracellular pathogens
- Acquired immunodeficiency syndrome (AIDS)
Diseases associated with Ab deficiencies / defects
- Agammaglobulinaemia (prone to **bacterial infections)
- **Sinusitis, **Otitis media, **Pneumonia
—> S. pneumoniae, H. influenzae, Meningococci, Mycoplasma
- ***Intestinal infection
—> Salmonella, Shigella, Campylobacter, Giardia, Rotavirus
- IgA deficiency
- Common condition
- Recurrent ***sinopulmonary infection
- Anaphylactic reaction if given IVIG (∵ patient may have Ab against IgA) - Nephrotic syndrome
- Prone to severe ***pneumococcal infection
Common variable immunodeficiency (CVID)
- Onset 15-25 yo
- Low level Ab
- Prone to infections:
—> **Sinopulmonary: recurrent bronchitis, sinusitis, otitis media, pneumonia (Encapsulated bacteria)
—> **GI
—> Systemic bacterial infections
- Other diseases: —> ***Autoimmune disease (∵ lost check-and-balance mechanisms in immune system) —> Malabsorption —> Granulomatous disease —> ↑ risk of GI malignancy, ***lymphoma
- Impaired cell-mediated immunity
***Intracellular pathogens
- Viruses
- HSV
- CMV
- VZV
- HHV6, 7
- HIV - Bacteria (Intracellular)
- Listeria
- Rhodococcus
- Salmonella
- Burkholderia pseudomallei
- Nocardia
- Mycobacterium (TB / NTM) - Fungus
- Pneumocystic jiroveci
- Cryptococcus
- Aspergillus species
- Dimorphic fungi e.g. Penicillium marneffei - Parasite
- Toxoplasma gondii
- Strongyloides stercoralis (hyperinfection and disseminated infection)
Acquired immunodeficiency syndrome (AIDS)
- Caused by HIV (Human immunodeficiency virus)
- Main problem: ↓ CD4+ T cells (after many years) —> Cell-mediated immunity most severely affected —> AIDS
- ∵ Master regulator depleted —> also affect other parts of immune system
- ***Tip: Always screen for HIV even slight suspicion —> Early detection of HIV is important!!!
Opportunistic infections (***Intracellular) in advanced HIV:
HK:
- MTB: only Extrapulmonary / if CD4<200: Pulmonary / LN
- PCP
- Penicilliosis (disseminated) (caused by Penicillium marneffei)
Others:
- Bacteria
- MAC / M. kansasii
- MTB
- NTM
- Salmonella septicaemia - Virus
- CMV
- HSV
- PML (progressive multifocal leukoencephalopathy) - Fungal
- candidiasis
- coccidioidomycosis
- cryptococcus
- histoplasmosis
- PCP - Parasite
- cryptosporidiosis
- isosporiasis
- toxoplasmosis - Cancer
- cervical cancer
- lymphoma - HIV-related
- encephalopathy
- wasting syndrome - Miscellaneous
- recurrent pneumonia
Important clinical syndromes associated with immune defects: Other systemic disease / conditions that affects immune functions
- **DM (hinder **neutrophil function)
- Breaks in physical barriers (e.g. skin, mucosa)
- ***Cirrhosis (liver cannot produce proteins, cannot filter blood)
- ***Autoimmune disease e.g. SLE
- ***Malignancy
- Transplantation
- ***Iron overload (pathogens love iron) (in repeated transfusion for Thalassaemia, Myelodysplastic syndrome)
- ***Splenectomy
- Drugs (e.g. steroids)
- Malnutrition
- Pregnancy
- Extremes of age
Post-splenectomy sepsis
Cause: Splenectomy / Functional hyposplenism
Major function of spleen in immunity:
- ***Production of Ab (esp. Ab against polysaccharide Ag)
- ***Clearance of encapsulated bacteria
Organism (mainly bacteria with polysaccharide capsule):
- ***S. pneumoniae
- ***Hib
- ***N. meningitidis
- Capnocytophaga canimorsus
Rapid progression:
- ***Need urgent antibiotics
Vaccination:
- S. pneumoniae
- Influenza
- Hib
- N. meningitidis
***Tip: Pay attention to patients with fever without a spleen —> immediate culture + antibiotics
Immunisation
Anything that ***Artificially induce immunity
Active vs Passive:
- Active: by Vaccination
- Passive: by Ig administration
Different types of vaccine:
- ***Whole organism: Live attenuated (e.g. MMR) / Inactivated (e.g. rabies)
- Toxoid (e.g. tetanus)
- ***Soluble capsular material (e.g. Pneumococcal vaccine)
- Recombinant proteins (e.g. HBV, HPV)
- Vector vaccines
- mRNA vaccines
How does immunisation work?
Exact mechanism is still poorly understood
By triggering:
- Humoral immunity (Elicit Ab response)
- Influenza vaccine
- Pneumococcal vaccine - Cell-mediated immunity
- e.g. BCG - Combination of both
Treatment of infectious disease by manipulating host immune system
- Reversing immunodeficient state
- Glucose control in DM
- HAART for HIV
- **G-CSF in patients with neutropenia
- **IVIG in patients with CVID - Administration of **immunomodulator —> help patients with refractory infectious diseases
- Naturally occurring cytokines
- **Immunoglobulins
- **Glucocorticoids
- Monoclonal Ab
- Synthetic compound with immunomodulatory activity
- Anticoagulant proteins e.g. activated protein C
- **Interferons
Interferons
Rationale: ***Antiviral activity
Treatment of: - HCV (PegIFN, now obsolete) - HBV (PegIFN, now obsolete) (- Kaposi sarcoma) (- Condyloma accuminatum) - COVID-19 (IFNβ (Type 1 IFN) may be useful in early disease according to local clinical trial)
Steroids
Rationale: ***Damp down inflammatory response —> Reduce detrimental effect due to inflammation
- ***Pneumocystis pneumonia (PCP)
- ***COVID-19 patients supplemental O2
- TB meningitis
- ***Bacterial meningitis (Dexamethasone)
- Chronic disseminated candidiasis
Intravenous immunoglobulin (IVIG)
Prepared from plasma obtained from many blood donors
MOA:
- Bind to pathogens / toxins
- ***Immunomodulation
Treatment of:
- ***Toxic shock syndrome due to Group A Strept / Staphylococcus (controversial)
- Parvovirus infection in immunocompromised patients
Prophylaxis (much more effective):
- Following exposure against VZV, measles, Hep A etc.
- Patients with ***humoral immunodeficiencies